logo
#

Latest news with #PubMatic

PUBM Q1 Earnings Call: CTV, Supply Path Optimization, and AI Drive Transformation Amid Ad Market Shifts
PUBM Q1 Earnings Call: CTV, Supply Path Optimization, and AI Drive Transformation Amid Ad Market Shifts

Yahoo

time4 days ago

  • Business
  • Yahoo

PUBM Q1 Earnings Call: CTV, Supply Path Optimization, and AI Drive Transformation Amid Ad Market Shifts

Programmatic advertising platform Pubmatic (NASDAQ: PUBM) announced better-than-expected revenue in Q1 CY2025, but sales fell by 4.3% year on year to $63.83 million. Guidance for next quarter's revenue was better than expected at $68 million at the midpoint, 0.6% above analysts' estimates. Its non-GAAP loss of $0.04 per share was $0.03 above analysts' consensus estimates. Is now the time to buy PUBM? Find out in our full research report (it's free). Revenue: $63.83 million vs analyst estimates of $62.09 million (4.3% year-on-year decline, 2.8% beat) Adjusted EPS: -$0.04 vs analyst estimates of -$0.07 ($0.03 beat) Adjusted Operating Income: -$2.21 million vs analyst estimates of -$14.38 million (-3.5% margin, 84.7% beat) Revenue Guidance for Q2 CY2025 is $68 million at the midpoint, roughly in line with what analysts were expecting EBITDA guidance for Q2 CY2025 is $10.5 million at the midpoint, below analyst estimates of $11.36 million Operating Margin: -18.6%, down from -8.3% in the same quarter last year Market Capitalization: $587.7 million PubMatic's first quarter performance was shaped by a mix of secular industry shifts and the company's evolving product focus. CEO Rajeev Goel highlighted strong momentum in connected TV (CTV), with revenues in that segment growing over 50% year-over-year, and noted that supply path optimization (SPO) accounted for a record 55% of total activity. Management also attributed underlying business growth to new products such as Activate for SPO and Convert for commerce media. The quarter was affected by continued softness in the display advertising segment, particularly linked to a large demand-side platform (DSP) partner, but Goel emphasized that excluding this factor and last year's political advertising, core business growth accelerated to 21%. Looking ahead, PubMatic's guidance is driven by expectations of continued secular shifts in digital advertising—most notably, increased spending on streaming over linear TV, and a transition from brand to performance-based advertising. Management believes these trends will benefit key product lines, especially CTV and commerce media. CFO Steve Pantelick emphasized the company's growing relationships with both major agency holding companies and mid-market DSPs, while Goel noted that the recent Google AdTech antitrust ruling could open additional opportunities for independent platforms. The ongoing adoption of AI-driven advertising tools is expected to further enhance efficiency and drive customer value. Management attributed the quarter's performance to rapid expansion in CTV, increased adoption of SPO, and growth in new product lines targeting commerce media and curation. CTV and video expansion: CTV remained a major growth engine, with over 50% year-over-year revenue gains, supported by deeper partnerships with leading streamers and international broadcasters. Goel noted 80% penetration among the top 30 streaming platforms. Supply path optimization (SPO) momentum: SPO represented a record 55% of PubMatic's total activity, as advertisers and agencies sought greater efficiency and transparency. Management sees SPO's share potentially reaching as high as 75% in coming years. Emerging products and curation: New revenue streams, especially from the Connect curation and data platform, more than doubled year-over-year. These solutions help advertisers better target audiences using first-party data and have become increasingly relevant as privacy concerns and data ownership shift industry dynamics. AI-driven platform launch: PubMatic introduced an AI-powered end-to-end platform, enabling buyers to use natural language to create and activate optimized campaigns. Early beta partners, such as GroupM, are testing this tool to improve campaign efficiency and targeting. Diversification of demand sources: The company reported accelerating activity from mid-market DSPs and direct advertisers, reflecting broader industry trends of budget consolidation and performance marketing. This diversification helps lessen reliance on large agency holding companies and single DSPs. PubMatic expects future growth to be driven by increasing adoption of programmatic CTV, AI-enabled advertising tools, and the ongoing shift to performance-focused digital campaigns. Secular shift to streaming and performance: Management expects advertisers to allocate more budgets toward streaming and lower-funnel, performance-based campaigns, as flexibility and measurable outcomes gain importance. This transition favors PubMatic's CTV and commerce media products, with anticipated benefits from higher demand and premium inventory. AI and operational efficiency: The expanded use of generative AI across the business, from campaign planning to internal engineering, is expected to enable faster innovation and productivity without increased headcount. AI-powered tools are projected to improve customer outcomes and streamline costs. Industry changes and regulatory impact: The Google AdTech antitrust verdict and changes in third-party cookie policies are seen as catalysts for independent platforms like PubMatic. Management anticipates potential market share gains as publishers and buyers seek alternatives to incumbent solutions, supported by ongoing investments in data-driven, privacy-compliant products. In the coming quarters, the StockStory team will track (1) the pace of CTV and AI product adoption across new and existing clients, (2) the impact of regulatory changes and the Google antitrust ruling on market share, and (3) further progress in diversifying demand away from large DSPs and agency holding companies. The effectiveness of cost control measures and the rollout of new AI-driven tools will also be key to monitoring operational leverage. PubMatic currently trades at a forward price-to-sales ratio of 1.9×. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it's free). Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Comscore and Adelaide Expand Access to High-Quality, Attention-Optimized Curated Deals across PubMatic's platform
Comscore and Adelaide Expand Access to High-Quality, Attention-Optimized Curated Deals across PubMatic's platform

Yahoo

time4 days ago

  • Business
  • Yahoo

Comscore and Adelaide Expand Access to High-Quality, Attention-Optimized Curated Deals across PubMatic's platform

New collaboration combines Comscore's trusted inventory rankings with Adelaide's attention metrics, enabling advertisers to drive higher engagement and maximize campaign impact RESTON, Va., June 10, 2025 (GLOBE NEWSWIRE) -- Comscore (NASDAQ: SCOR), a global leader in measuring and analyzing consumer behaviors, today announced the expansion of its Comscore-Certified Deal IDs to include Adelaide's attention-based metric in PubMatic's premium sell-side supply including many of the top CTV publishers. Adelaide is a leader in attention-based media measurement and PubMatic is a leading technology platform that enables publishers to manage and monetize their digital advertising inventory programmatically. This collaboration enables media buyers to reach top-quality inventory certified by Comscore, with placements strategically optimized through Adelaide's attention-based metrics. By integrating these insights into a seamless programmatic solution across PubMatic's premium inventory, advertisers can help ensure their campaigns appear in placements that drive the highest engagement and impact—maximizing business outcomes. 'At Comscore, we are committed to providing media buyers with the tools they need to drive performance and transparency in programmatic advertising,' said Rachel Gantz, Managing Director, Proximic by Comscore. 'This integration aligns with Comscore's mission to unify disparate parts of the ad ecosystem, bringing together trusted Comscore data solutions with key industry partners to enable advertisers to activate campaigns with confidence and drive outcomes that matter.' A first-of-its-kind programmatic curation solution, Comscore-Certified Deal IDs unifies two of Comscore's flagship solutions – marrying its industry-leading content measurement with its Proximic programmatic targeting capabilities. 'Combining Adelaide's media quality metric, AU, with Comscore's trusted independent inventory quality signals in PubMatic makes targeting premium inventory easy for media buyers,' said Marc Guldimann, CEO and co-founder at Adelaide. 'With this partnership, advertisers can seamlessly activate programmatic campaigns with confidence that they're getting the best value for their media investment.' 'By enabling Comscore-Certified Deal IDs in our SSP, we are expanding opportunities for advertisers to buy high-quality inventory with enhanced transparency and efficiency,' said Howard Luks, VP of Audience Solutions at PubMatic. 'This initiative is part of PubMatic's vision to develop the technology, infrastructure and partnerships that power a performant open internet. Through programmatic advertising with data-driven curation, we are committed to creating a more transparent, efficient and impactful digital ecosystem. We're excited to partner with Comscore and Adelaide to empower media buyers with the data they need to maximize their ad spend.' With this latest integration, Comscore continues solidifying its role as an independent, third-party authority in inventory quality measurement, providing advertisers the tools to maximize media effectiveness across the programmatic ecosystem. About ComscoreComscore is a global, trusted partner for planning, transacting and evaluating media across platforms. With a data footprint that combines digital, linear TV, over-the-top and theatrical viewership intelligence with advanced audience insights, Comscore empowers media buyers and sellers to quantify their multiscreen behavior and make meaningful business decisions with confidence. A proven leader in measuring digital and TV audiences and advertising at scale, Comscore is the industry's emerging third-party source for reliable and comprehensive cross-platform measurement. Media Contact:Marie ScoutasComscorepress@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Here Are All 6 Stocks I've Bought Through 5 Months of 2025
Here Are All 6 Stocks I've Bought Through 5 Months of 2025

Yahoo

time05-06-2025

  • Business
  • Yahoo

Here Are All 6 Stocks I've Bought Through 5 Months of 2025

President Donald Trump's tariff-induced stock swoon rolled out the red carpet for investors to snag high-quality stocks at a discount. Buying stocks and holding those positions for multiple years is ingrained into my investment philosophy. High-yield dividend stocks, a deeply-discounted legal monopoly, a uniquely-positioned growth stock, and a handful of turnaround candidates were on my buy list through May. 10 stocks we like better than Pfizer › It's been a wild ride for the stock market through the first five months of 2025. As of mid-February, Wall Street's major stock indexes could do no wrong, with the benchmark S&P 500 vaulting to an all-time record-closing high. But over the next two months, tariff-related uncertainty pushed the Nasdaq Composite into its first bear market in three years, and weighed the S&P 500 down to near-bear market territory. Historically, double-digit percentage declines in the major stock indexes represent ideal opportunities for long-term investors to pounce. As of this writing on June 2, I hold 38 positions in my portfolio -- 37 stocks and one exchange-traded fund (ETF) -- and only four of these stakes have been held for less than a year. Buying and holding stocks for years is ingrained into my investment philosophy. With volatility begetting opportunity, here are all six stocks I've bought through the first five months of 2025. One of the new holdings I added to my portfolio this year is pharmaceutical titan Pfizer (NYSE: PFE). The two separate purchases I've made gave me a cost basis of $23.47 per share, which is a penny above where shares closed on June 2. What makes Pfizer so attractive is that it's been punished for its own success. After generating north of $56 billion in combined sales for its COVID-19 vaccine (Comirnaty) and oral therapy (Paxlovid) in 2022, combined sales tumbled to around $11 billion in 2024. But even if these sales fall again in 2025, Pfizer has, collectively, grown its net product revenue by more than 50% over four years. The shortsightedness of select investors is creating a significant buying opportunity for long-term-minded investors. Additionally, Pfizer's oncology segment can be a key growth driver in the years to come. It completed a $43 billion acquisition of cancer-drug developer Seagen in December 2023. This deal added more than $3 billion in immediate sales to Pfizer's oncology portfolio, as well as vastly expanded its pipeline. With Pfizer also targeting billions of dollars in annual cost-savings, a forward price-to-earnings (P/E) ratio of less than 8, coupled with a dividend yield of more than 7%, was too enticing to pass up. The stock I've unquestionably put the most money to work in this year is adtech company PubMatic (NASDAQ: PUBM). I've more than doubled my stake in the company since late February, with a cost basis from shares purchased this year of $9.29. PubMatic is perfectly positioned to take advantage of businesses shifting their ad dollars from print and billboards to digital channels, such as video, mobile, and connected TV (i.e., streaming content). PubMatic's cloud-based programmatic ad platform assists publishers in selling their digital display space. Aside from digital advertising offering sustained double-digit sales growth, PubMatic will benefit from its decision to build out its cloud infrastructure platform. Though it would have been easier to rely on a third party, taking the time to build out this critical infrastructure will now allow PubMatic to hang onto more of its revenue as it scales. This should lead to superior margins, relative to other sell-side providers. Furthermore, PubMatic is swimming with cash. It's been generating positive operating cash flow for a decade and has been aggressively repurchasing its own stock. When backing out its cash position, investors are paying less than $9 per share for a company fully capable of producing more than $1 in earnings per share in a thriving economy. Although the stock market is historically pricey, select value stocks can be found. Satellite-radio operator Sirius XM Holdings (NASDAQ: SIRI) certainly fits the bill. The one add I made to my existing Sirius XM stake came at $19.28 per share on April 4. The great thing about Sirius XM is that it's a legal monopoly. Even though it's still fighting for listeners with traditional radio companies, being the only licensed satellite-radio operator does afford the company some degree of subscription pricing power. Even more important, Sirius XM generates the bulk of its revenue differently than terrestrial and online radio companies. Whereas the latter are heavily reliant on advertising, Sirius XM generates a little over three-quarters of its net sales from subscriptions. When recessions do occur, subscribers are far less likely to cancel their service than businesses are to meaningfully pare back their ad spending. On paper, this makes Sirius XM's operating cash flow far more predictable. Sirius XM's forward P/E of 7, when combined with a dividend yield that's currently above 5%, makes for a tantalizing buy. Semiconductor behemoth Intel (NASDAQ: INTC) is another long-term holding that I chose to add to during President Donald Trump's tariff-induced market swoon. The lone addition was made on April 8 at $18.56. My wager on Intel is that management can eventually turn around a business that was late to the artificial intelligence (AI) party. While Intel's graphics processing units (GPUs) haven't exactly flown off the shelves like Nvidia's hardware, AI is a massive enough addressable market that even latecomers with established brand names can thrive. Despite its GPU tardiness, Intel's central processing units (CPUs) continue to play a key role in high-compute data centers and traditional desktops/laptops. Even with Advanced Micro Devices chipping away at Intel's once monopoly like CPU market share, Intel remains the decisive leader. The robust cash flow generated from its CPU sales can help Intel redirect capital to higher-growth initiatives. While trading in the mid-$18s, Intel stock was also nearing its tangible book value and had fallen 19% below its listed book value, as of the most recent quarter. Though book value is just one of many valuation measures, I believe there are enough levers to pull and long-term catalysts for Intel stock to bounce back. Specialty drugmaker BioMarin Pharmaceutical (NASDAQ: BMRN) is another holding I've purchased for the first time in 2025. My lone purchase occurred on April 8 at a cost basis of $56.01. One of the variables that makes BioMarin such an attractive investment is its focus on ultrarare diseases. Though the clinical success rate in treating rare diseases can be dicey, positive clinical trials can lead to approved therapies that face little or no competition. What's more, insurers rarely push back on high list prices for rare-disease drugs that have no alternatives. BioMarin's shining star for the moment is Voxzogo, a drug used to treat achondroplasia, which is a common type of dwarfism. A combination of strong pricing power and label expansion opportunities should lead to Voxzogo eventually topping $1 billion in annual sales. Further, BioMarin is targeting $4 billion in annual sales by 2027, which would be up from $2.85 billion in reported sales for 2024. Given the exceptionally high margins associated with ultrarare-disease drugs, BioMarin's forward P/E of 10.6, and its projected low-double-digit sales growth rate, make its stock quite the bargain. Last but not least, I added to my existing position in edge cloud-computing company Fastly (NYSE: FSLY) during the Trump tariff tumble. The only addition came on April 4 at a cost of $5.08 per share. Similar to Intel, Fastly is a work in progress that isn't going to right itself overnight. The investment thesis here is that as businesses shift their data and that of their customers online and into the cloud, demand for rapid and secure content delivery network (CDN) services will only increase. Fastly aggressively expanded the capabilities of its CDN following the pandemic. Although not all of Fastly's key performance indicators (KPIs) have moved in the right direction, some of the most important KPIs suggest management is making the right moves. For instance, its revenue retention rate is locked in at 99% or higher, and its enterprise customer count, while a bit volatile, has been chopping its way higher. Perhaps the most exciting number in Fastly's latest quarter is its remaining performance obligation (i.e., its backlog), which surged above $300 million. Considering that Fastly is generating positive operating cash flow, the foundation for future profits has been laid. Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $656,825!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $865,550!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Sean Williams has positions in BioMarin Pharmaceutical, Fastly, Intel, Pfizer, PubMatic, and Sirius XM. The Motley Fool has positions in and recommends Advanced Micro Devices, Fastly, Intel, Nvidia, Pfizer, and PubMatic. The Motley Fool recommends BioMarin Pharmaceutical and recommends the following options: short August 2025 $24 calls on Intel. The Motley Fool has a disclosure policy. Here Are All 6 Stocks I've Bought Through 5 Months of 2025 was originally published by The Motley Fool Sign in to access your portfolio

Q1 Earnings Roundup: PubMatic (NASDAQ:PUBM) And The Rest Of The Advertising Software Segment
Q1 Earnings Roundup: PubMatic (NASDAQ:PUBM) And The Rest Of The Advertising Software Segment

Yahoo

time03-06-2025

  • Business
  • Yahoo

Q1 Earnings Roundup: PubMatic (NASDAQ:PUBM) And The Rest Of The Advertising Software Segment

As the Q1 earnings season comes to a close, it's time to take stock of this quarter's best and worst performers in the advertising software industry, including PubMatic (NASDAQ:PUBM) and its peers. The digital advertising market is large, growing, and becoming more diverse, both in terms of audiences and media. As a result, there is a growing need for software that enables advertisers to use data to automate and optimize ad placements. The 7 advertising software stocks we track reported a strong Q1. As a group, revenues beat analysts' consensus estimates by 4.8% while next quarter's revenue guidance was 1.3% below. Luckily, advertising software stocks have performed well with share prices up 10.5% on average since the latest earnings results. Founded in 2006 as an online ad platform helping ad sellers, Pubmatic (NASDAQ: PUBM) is a fully integrated cloud-based programmatic advertising platform. PubMatic reported revenues of $63.83 million, down 4.3% year on year. This print exceeded analysts' expectations by 2.8%. Despite the top-line beat, it was still a mixed quarter for the company with an impressive beat of analysts' EBITDA estimates. 'We are pleased with our Q1 performance, exceeding guidance on both the top and bottom line driven by the secular growth areas in our business. Ongoing investments in product innovation and go to market teams drove 21% year over year growth in our underlying business, with momentum carrying into April,' said Rajeev Goel, co-founder and CEO at PubMatic. PubMatic delivered the slowest revenue growth of the whole group. The stock is up 10.5% since reporting and currently trades at $12.14. Is now the time to buy PubMatic? Access our full analysis of the earnings results here, it's free. Founded by former Microsoft engineers Jeff Green and Dave Pickles, The Trade Desk (NASDAQ:TTD) offers cloud-based software that uses data to help advertisers better plan, place, and target their online ads. The Trade Desk reported revenues of $616 million, up 25.4% year on year, outperforming analysts' expectations by 7%. The business had a very strong quarter with a solid beat of analysts' EBITDA estimates and an impressive beat of analysts' billings estimates. The market seems happy with the results as the stock is up 24.5% since reporting. It currently trades at $74.70. Is now the time to buy The Trade Desk? Access our full analysis of the earnings results here, it's free. Started in 2011 as a spin-out of RapLeaf, LiveRamp (NYSE:RAMP) is a software-as-a-service provider that helps companies better target their marketing by merging offline and online data about their customers. LiveRamp reported revenues of $188.7 million, up 9.8% year on year, exceeding analysts' expectations by 1.3%. Still, it was a mixed quarter as it posted full-year guidance of slowing revenue growth. LiveRamp delivered the weakest performance against analyst estimates in the group. The company added 3 enterprise customers paying more than $1 million annually to reach a total of 128. Interestingly, the stock is up 15.3% since the results and currently trades at $32.37. Read our full analysis of LiveRamp's results here. Founded in 2009, Integral Ad Science (NASDAQ:IAS) provides digital advertising verification and optimization solutions, ensuring that ads are viewable by real people in brand-safe environments across various platforms and devices. Integral Ad Science reported revenues of $134.1 million, up 17.1% year on year. This print topped analysts' expectations by 3.2%. More broadly, it was a mixed quarter as it also produced a solid beat of analysts' EBITDA estimates. Integral Ad Science had the weakest full-year guidance update among its peers. The stock is flat since reporting and currently trades at $8.15. Read our full, actionable report on Integral Ad Science here, it's free. Co-founded by former Apple CEO John Sculley, Zeta Global (NYSE:ZETA) provides software and data analytics tools that help companies market their products to billions of customers. Zeta reported revenues of $264.4 million, up 35.6% year on year. This number surpassed analysts' expectations by 4.1%. Overall, it was a strong quarter as it also recorded an impressive beat of analysts' EBITDA estimates and a solid beat of analysts' billings estimates. Zeta achieved the highest full-year guidance raise among its peers. The stock is down 5.1% since reporting and currently trades at $12.85. Read our full, actionable report on Zeta here, it's free. The Fed's interest rate hikes throughout 2022 and 2023 have successfully cooled post-pandemic inflation, bringing it closer to the 2% target. Inflationary pressures have eased without tipping the economy into a recession, suggesting a soft landing. This stability, paired with recent rate cuts (0.5% in September 2024 and 0.25% in November 2024), fueled a strong year for the stock market in 2024. The markets surged further after Donald Trump's presidential victory in November, with major indices reaching record highs in the days following the election. Still, questions remain about the direction of economic policy, as potential tariffs and corporate tax changes add uncertainty for 2025. Want to invest in winners with rock-solid fundamentals? Check out our Strong Momentum Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. Sign in to access your portfolio

Pixalate Releases Q1 2025 Global Connected TV (CTV) Ad Supply Chain Trends Reports: Open Programmatic Ad Spend Rises 10% YoY to $5 Billion, Ad Fraud (IVT) Hits 18%
Pixalate Releases Q1 2025 Global Connected TV (CTV) Ad Supply Chain Trends Reports: Open Programmatic Ad Spend Rises 10% YoY to $5 Billion, Ad Fraud (IVT) Hits 18%

Yahoo

time29-05-2025

  • Business
  • Yahoo

Pixalate Releases Q1 2025 Global Connected TV (CTV) Ad Supply Chain Trends Reports: Open Programmatic Ad Spend Rises 10% YoY to $5 Billion, Ad Fraud (IVT) Hits 18%

According to Pixalate's estimates, global open programmatic CTV ad spend rose 10% year-over-year to $5.02 billion in Q1 2025; Global invalid Traffic (IVT), including ad fraud, in CTV hit 18% in Q1 2025 - up from 12% in Q1 2024; Regional IVT rates show APAC (36% IVT rate) hit the hardest, followed by EMEA (30%), Latin America (24%), and North America (18%); Roku devices had the lowest global IVT rate at 11%, while Samsung Smart TVs had the highest at 36% London, May 29, 2025 (GLOBE NEWSWIRE) -- Pixalate, the leading global platform for ad fraud protection, privacy, and compliance analytics, today released the Q1 2025 Global Connected TV (CTV) Ad Supply Chain Trends Report. The report comprehensively analyzes the state of open programmatic CTV advertising in Q1 2025 across key global ad economies. In addition to the Global report, Pixalate released versions for the United States, Canada, the United Kingdom, and Mexico. The reports include CTV ad spend trends globally and in key global ad economies across Roku, Samsung Smart TV, Amazon Fire TV, and Apple TV. The comprehensive reports overview the programmatic ad supply chain by examining sell-side platform (SSP) market share, top-grossing CTV apps, CTV device market share trends, invalid traffic trends (IVT, including ad fraud), and more. Q1 2025 Global CTV Ad Supply Chain Trends Report Key Findings Global CTV Ad Spend: Global Open Programmatic CTV Ad Spend: Estimated at $5 billion in Q1 2025, up 10% year-over-year (YoY) Global CTV Ad Fraud (IVT): CTV Invalid Traffic (including Ad Fraud) Rate: The IVT rate for global open programmatic CTV traffic stands at 18%, down from 24% during the Q4 2024 holiday season but up 50% year-over-year (from 12% in Q1 2024) By Country: Canada had a 26% IVT rate, Mexico had a 22% IVT rate, while the United Kingdom (UK) saw a 24% IVT, followed by the United States (U.S.) at 18% By Region: APAC saw the highest regional IVT rate at 36%, followed by EMEA at 30%, LATAM at 24%, and North America at 18%. IVT Rate by Device: Roku devices had the lowest global IVT rate (11%), while Samsung Smart TV devices had the highest (36%). Apple TV stood at 20% while Amazon Fire TV had a 16% IVT rate CTV SSP (Sell-Side Platform) Market Share: Magnite led on Roku in the U.S. with 32% market share, while FreeWheel was among the top two across Roku (18%), Amazon Fire TV (15%), Apple TV (13%), and Samsung Smart TV (17%) In the U.S., PubMatic ranked top-five across all four platforms: Roku (8%), Amazon Fire TV (10%), Apple TV (10%), Samsung Smart TV (12%) In Mexico, PubMatic, Google AdExchange, and Verve each held an 18% market share on Roku CTV Device Market Share: Roku led in market share with 38% in North America, 48% in LATAM In North America, Amazon Fire TV (18%) was second, followed by Apple TV (13%) Samsung Smart TV led in APAC (24%) and EMEA (25%) LG was a close second in EMEA (25%), followed by Amazon (13%) and Roku (11%) Top Grossing Apps 'Hulu' generated approximately $161 million in open programmatic ad revenue in the U.S. 'TalkTV' led on both Apple TV and Amazon Fire TV in the UK In Mexico, 'ViX' took the No. 1 spot on Roku, Amazon Fire TV, and Samsung Smart TV In Canada, 'Crackle' led on Apple TV, closely followed by 'Food Network GO' Pixalate's data science team analyzed programmatic advertising activity across over 100 thousand Connected TV (CTV) apps and over 7 billion global open programmatic ad transactions in Q1 2025 to compile the research in this series. Download the Q1 2025 CTV Ad Supply Chain Trends Reports United States Canada United Kingdom Mexico Global About Pixalate Pixalate is a global platform specializing in privacy compliance, ad fraud prevention, and digital ad supply chain data intelligence. Founded in 2012, Pixalate is trusted by regulators, data researchers, advertisers, publishers, ad tech platforms, and financial analysts across the Connected TV (CTV), mobile app, and website ecosystems. Pixalate is accredited by the MRC for the detection and filtration of Sophisticated Invalid Traffic (SIVT). DisclaimerThe content of this press release, and Global Connected TV (CTV) Ad Supply Chain Trends Reports, reflect Pixalate's opinions with respect to factors that Pixalate believes can be useful to the digital media industry. Any data shared is grounded in Pixalate's proprietary technology and analytics, which Pixalate is continuously evaluating and updating. Any references to outside sources should not be construed as endorsements. Pixalate's opinions are just that, opinions, which means that they are neither facts nor guarantees. Pixalate is sharing this data not to impugn the standing or reputation of any entity, person or app, but, instead, to report findings and trends pertaining to programmatic advertising activity across CTV apps in the time period studied. Pixalate does not independently verify third-party information. Per the Media Rating Council (MRC), "'Invalid Traffic' is defined generally as traffic that does not meet certain ad serving quality or completeness criteria, or otherwise does not represent legitimate ad traffic that should be included in measurement counts. Among the reasons why ad traffic may be deemed invalid is it is a result of non-human traffic (spiders, bots, etc.), or activity designed to produce fraudulent traffic." Certain IVT is also sometimes referred to as "ad fraud." Per the MRC, "'Fraud' is not intended to represent fraud as defined in various laws, statutes and ordinances or as conventionally used in U.S. Court or other legal proceedings, but rather a custom definition strictly for advertising measurement purposes." CONTACT: Nina Talcott ntalcott@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store